- Home
- DOYU vs CLPT Comparison
DOYU vs CLPT Comparison
Compare DOYU & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOYU | CLPT |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.0M | 353.5M |
| IPO Year | 2019 | 2009 |
Fundamental Metrics
Financial Performance| Metric | DOYU | CLPT |
|---|---|---|
| Price | $4.51 | $12.25 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $20.00 |
| AVG Volume (30 Days) | 18.5K | ★ 476.8K |
| Earning Date | 05-19-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | N/A | $45.67 |
| Revenue Next Year | N/A | $19.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $4.28 | $8.27 |
| 52 Week High | $9.34 | $30.10 |
Technical Indicators
Market Signals| Indicator | DOYU | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 35.97 | 54.68 |
| Support Level | $4.28 | $10.09 |
| Resistance Level | $5.13 | $15.09 |
| Average True Range (ATR) | 0.17 | 0.95 |
| MACD | -0.03 | 0.10 |
| Stochastic Oscillator | 25.80 | 53.57 |
Price Performance
Historical ComparisonAbout DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.